arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

NEPHROS INC

NEPH
$3.11 ▼ -0.09 (-2.81%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

NEPHROS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $33.0M
Dividend Yield —
Revenue Growth 32.7% ↗
Op. Margin 6.1% ↗
ROIC None
FCF / Share $0.16 ↗
Trailing P/E 28.3x
Price / Book —
FCF Yield 5.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.79M
↑ +32.7% —
Net Income Profit after all expenses
$1.19M
↑ +1513.5% —
Operating Margin Operating profit as % of sales
6.1%
↑ +14296.4% 46th
FCF / Share Free cash flow per share
$0.16
↑ +398.3% —
Long-Term Debt Long-term obligations
$71.00K
↓ -88.0% —

Health Breakdown

Profitability
52
Financial Health
99
Cash Quality ↑
78

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 66 quarters